Suchergebnisse - "Tarumoto, Norihito"

PubPharm (92)

21

Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test

enthalten in: Journal of medical virology | 2022

von Kitagawa, Y. | Imai, K. | Matsuoka, M. | +9

22

HbA1c level may be a risk factor for oxygen therapy requirement in patients with coronavirus disease 2019

enthalten in: Journal of Diabetes Investigation | 2022

von Yanagisawa, S. | Oikawa, Y. | Takagi, S. | +11

23

Evaluation of the correlation between the access SARS‐CoV‐2 IgM and IgG II antibody tests with the SARS‐CoV‐2 surrogate virus neutralization test

enthalten in: Journal of Medical Virology | 2022

von Kitagawa, Y. | Imai, K. | Matsuoka, M. | +9

24

Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy : A Randomized, Phase III Clinical Trial

enthalten in: Infectious diseases and therapy | 2021

von Shinkai, M. | Tsushima, K. | Tanaka, S. | +36

25

Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19 : The VITROS® SARS-CoV-2 Antigen Test

enthalten in: Journal of medical virology | 2021

von Matsuzaki, N. | Orihara, Y. | Kodana, M. | +8

26

Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial

enthalten in: Infectious diseases and therapy | 2021

von Shinkai, M. | Tsushima, K. | Tanaka, S. | +36

27

Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial

enthalten in: Infectious diseases and therapy | 2021

von Shinkai, M. | Tsushima, K. | Tanaka, S. | +36

28

Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial

enthalten in: Infectious diseases and therapy | 2021

von Shinkai, M. | Tsushima, K. | Tanaka, S. | +36

29

Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays

enthalten in: Diagnostic microbiology and infectious disease | 2021

von Kubota, K. | Kitagawa, Y. | Matsuoka, M. | +9

30

Concerns about the clinical usefulness of saliva specimens for the diagnosis of COVID-19

enthalten in: The Journal of infection | 2021

von Kodana, M. | Kitagawa, Y. | Takahashi, R. | +10

CommentOn: J Infect. 2020 Jul;81(1):e45-e50. - PMID 32298676